Scalp Nerve Block and Opioid Consumption in Brain Surgery
NCT ID: NCT02057367
Last Updated: 2016-07-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
100 participants
INTERVENTIONAL
2013-03-31
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Scalp Nerve Block on Postoperative Pain, Hemodynamics and Surgical Stress Response in Craniotomy Surgery
NCT06748547
Effects of Pre-emptive Scalp Infiltration With Ketorolac and Ropivacaine for Post-craniotomy Pain
NCT04141319
Pre- vs. Postoperative Scalp Block for Pain Control After Supratentorial Craniotomy
NCT04344132
Effects of SCALP Block on Postoperative Analgesia in Craniotomy Surgery
NCT06588751
Pre-emptive Scalp Infiltration With Methylprednisolone Plus Ropivacaine for Postoperative Pain After Craniotomy
NCT04078139
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A Prospective Randomized Double Blind Control
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Scalp block with 0.5% plain marcaine
Anterior scalp block with 0.5% plain Marcaine 20 ml.
Scalp block with 0.5% plain Marcaine
Anterior scalp block will be done by using 0.5% plain Marcaine 20 ml.
Scalp block with 0.9% normal saline
Anterior scalp block with 0.9% normal saline 20 ml.
Scalp block with 0.9% normal saline
Anterior scalp block will be done by using 0.9% normal saline 20 ml.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Scalp block with 0.5% plain Marcaine
Anterior scalp block will be done by using 0.5% plain Marcaine 20 ml.
Scalp block with 0.9% normal saline
Anterior scalp block will be done by using 0.9% normal saline 20 ml.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients have been scheduled to undergo an elective craniotomy to remove tumor in any surgical position
3. Patients have been general anesthetized with endotracheal intubation and control ventilation
4. Patients who have provided consent for the participation in the research and for the use of their medical record in research
Exclusion Criteria
2. Patients who have a history of local anesthetic allergy and/ or anaphylaxis
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chiang Mai University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pathomporn Pin on, M.D.
Department of Anesthesiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pathomporn Pin-on, M.D.
Role: PRINCIPAL_INVESTIGATOR
Chiang Mai University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chiang Mai University
Chiang Mai, Chiang Mai, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANE2556-01510
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.